This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
Combined deletion of MEN1, ATRX and PTEN triggers development of high-grade pancreatic neuroendocrine tumors in mice
Scientific Reports Open Access 12 April 2024
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$29.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Original article
Issa, G. C. et al. The menin inhibitor revumenib in KMT2A-rearranged or NPM1-mutant leukaemia. Nature https://doi.org/10.1038/s41586-023-05812-3 (2023)
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Killock, D. Menin–KMT2A interaction inhibitor shows promise. Nat Rev Clin Oncol 20, 284 (2023). https://doi.org/10.1038/s41571-023-00759-w
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41571-023-00759-w